Skip to main content

Table 3 Number of patients with moderate to severe hypophosphataemia (serum PO4 < 0.6 mmol/L) according to visit day following ferric carboxymaltose (FCM)

From: Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

Visit day

IBD (n = 24)

Non-IBD (n = 20)

Day 0

0

0

Day 2

1

2

Day 4

3

4

Day 7

9

5

Day 14

7

10

Day 28

1

2